PIK3CA and AKT1 mutations were found to be particularly enriched in the luminal B/HER2− subtype, NF1, and ERBB2 mutations were enriched in the luminal B/HER2+ mutation, and PTEN mutations were enriched in triple-negative breast cancer. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.